Combined preconditioning and postconditioning provides synergistic protection against liver ischemic reperfusion injury

International Journal of Biological Sciences

Volumn 8, Issue 5, 2012, Pages 707-718

  Song, Xiaoyu ^a   Zhang, Ning ^a   Hu, Hongde ^a   Cao, Liu ^a   Zhang, Haipeng ^a  

^a CHINA MEDICAL UNIVERSITY   (China)

Author keywords

Ischemia; Postconditioning; Preconditioning; Proanthocyanidins; Reperfusion Injury

Indexed keywords

REACTIVE OXYGEN METABOLITE;

ANIMAL; ARTICLE; ISCHEMIC POSTCONDITIONING; ISCHEMIC PRECONDITIONING; LIVER; MALE; METABOLISM; MOUSE; PATHOLOGY; REPERFUSION INJURY;

ANIMALS; ISCHEMIC POSTCONDITIONING; ISCHEMIC PRECONDITIONING; LIVER; MALE; MICE; REACTIVE OXYGEN SPECIES; REPERFUSION INJURY;

MURINAE; VITACEAE;

EID: 84863731554     PISSN: 14492288     EISSN: None     Source Type: Journal    
DOI: 10.7150/ijbs.4231     Document Type: Article

References (37)

1. Jaeschke H. Molecular mechanisms of hepatic ischemia-reperfusion injury and preconditioning. Am J Physiol Gastrointest Liver Physiol. 2003; 284(1): G15-G26.
2. Rougemont O, Lehmann K, Clavien PA. Preconditioning, organ preservation, and postconditioning to prevent ischemia-reperfusion injury to the liver. Liver Transpl. 2009; 15(10):1172-1182.
3. Ambros JT, Herrero-Fresneda I, Borau OG, Boira JM. Ischemic preconditioning in solid organ transplantation: from experimental to clinics. Transpl Int. 2007; 20(3): 219-229.
4. Zhou G, Dada LA, Wu M, Kelly A, Trejo H, Zhou Q, et al. Hypox-ia-induced alveolar epithelial-mesenchymal transition requires mi-tochondrial ROS and hypoxia-inducible factor 1. Am J Physiol Lung Cell Mol Physiol. 2009; 297(6): 1120-1130.
5. Penna C, Mancardi D, Rastaldo R, Pagliaro P. Cardioprotection: A radical view Free radicals in pre and postconditioning. Biochim Biophys Acta. 2009; 1787(7): 781-793
6. Sínay L, Kürthy M, Horváth S, Arató E, Shafiei M, Lantos J, et al. Ischemic postconditioning reduces peroxide formation, cytokine expression and leukocyte activation in reperfusion injury after ab-dominal aortic surgery in rat model. Clin Hemorheol Microcirc. 2008; 40(2):133-142.
7. Kin H, Wang NP, Mykytenko J, Reeves J, Deneve J, Jiang R, et al. Inhibition of myocardial apoptosis by postconditioning is associ-ated with attenuation of oxidative stress-mediated nuclear fac-tor-kappa B translocation and TNF alpha release. Shock. 2008; 29(6):761-768.
8. Jia C. Advances in the regulation of liver regeneration. Expert Rev Gastroenterol Hepatol. 2011; 5(1): 105-121.
9. Lauzier B, Delemasure S, Debin R, Collin B, Sicard P, Acar N, et al. Beneficial effects of myocardial postconditioning are associated with reduced oxidative stress in a senescent mouse model. Trans-plantation. 2008; 85(12): 1802-1808.
10. Raat NJ, Shiva S, Gladwin MT. Effects of nitrite on modulating ROS generation following ischemia and reperfusion. Adv Drug Deliv Rev. 2009; 61(4): 339-350.
11. Zaouali MA, Ben Mosbah I, Boncompagni E, Ben Abdennebi H, Mitjavila MT, Bartrons R, et al. Hypoxia inducible factor-1alpha ac-cumulation in steatotic liver preservation: role of nitric oxide. World J Gastroenterol. 2010; 16(28):3499-3509.
12. Koshikawa N, Hayashi J, Nakagawara A, Takenaga K. Reactive oxygen species-generating mitochondrial DNA mutation up-regulates hypoxia-inducible factor-1alpha gene transcription via phosphatidylinositol 3-kinase-Akt/protein kinase C/histone deacetylase pathway. J Biol Chem. 2009; 284(48):33185-33194.
13. Molitoris KH, Kazi AA, Koos RD. Inhibition of oxygen-induced hypoxia-inducible factor-1alpha degradation unmasks estradiol induction of vascular endothelial growth factor expression in ECC-1 cancer cells in vitro. Endocrinology. 2009; 150(12):5405-5414.
14. Paddenberg R, Howold N, Hoger C, Janssen H, Grau V, Kummer W. Organ preservation solutions attenuate accumulation and nuclear translocation of hypoxia-inducible factor-1alpha in the hepatoma cell line HepG2. Cell Biochem Funct. 2009; 27(8): 516-525.
15. Amersi F, Buelow R, Kato H, Ke B, Coito AJ, Shen XD, et al. Upreg-ulation of heme oxygenase-1 protects genetically fat Zucker rat liv-ers from ischemia/reperfusion injury. J Clin Invest. 1999; 104(11): 1631-1639.
16. Law AY, Wong CK. Stanniocalcin-2 is a HIF-1 target gene that promotes cell proliferation in hypoxia. Exp Cell Res. 2010; 316 (3): 466-476.
17. Lemus ML, Flores ME, Cervantes R, Torres BM, Gudiño G, Chaparro V, et al. Expression of HIF-1 alpha, VEGF and EPO in peripheral blood from patients with two cardiac abnormalities associated with hypoxia. Clin Biochem. 2010; 43(3): 234-239.
18. Gessi S, Fogli E, Sacchetto V, Merighi S, Varani K, Preti D, et al. Adenosine modulates HIF-1{alpha}, VEGF, IL-8, and foam cell formation in a human model of hypoxic foam cells. Arterioscler Thromb Vasc Biol. 2010; 30(1):90-97.
19. Bockhorn M, Goralski M, Prokofiev D, Dammann P, Grünewald P, Trippler M, et al. VEGF is important for early liver regeneration af-ter partial hepatectomy. J Surg Res. 2007; 138(2): 291-299.
20. Hausenloy Derek J, Yellon Derek M. Preconditioning and postcon-ditioning: Underlying mechanisms and clinical application. Ather-osclerosis. 2009; 204(2): 334-341.
21. Eltzschig HK, Eckle T. Ischemia and reperfusion--from mechanism to translation. Nature Medicine. 2011; 17(11): 1391-1401.
22. De Rougemont O, Dutkowski P, Clavien P.A. Biological modulation of liver ischemia-reperfusion injury. Curr Opin Organ Transplant. 2010; 15(2): 183-189.
23. De Rougemont O, Lehmann K, Clavien P.A. Preconditioning, Organ Preservation, and Postconditioning to Prevent Ische-mia-Reperfusion Injury to the Liver. Liver Transpl. 2009; 15(2): 1172-1182.
24. Zhao ZQ, Corvera JS, Halkos ME, Kerendi F, Wang NP, Guyton RA, Vinten J. Inhibition of myocardial injury by ischemic posteondi-tioning during reperfusion: comparison with ischemic precondi-tioning. Am J Physiol Heart Circ Physiol.2003; 285(2):579-588.
25. Tapuria N, Kumar Y, Habib MM, Abu Amara M, Seifalian AM, Da-vidson BR. Remote postconditioning: A novel protective method from ischemia reperfusion injury-A review. J Surg Res. 2008; 150(2): 304-330.
26. Kanoria S, Jalan R, Seifalian AM, Williams R, Davidson BR. Protocols and mechanisms for remote ischemic preconditioning: a novel method for reducing ischemia reperfusion injury. Transplantation. 2007; 84(4):445-458.
27. Saxena P, Newman MA, Shehatha JS, Redington AN, Konstantinov IE. Remote ischemic conditioning: evolution of the concept, mecha-nisms, and clinical application. J Card Surg. 2010; 25(1):127-134.
28. Thibault Helene, Piot Christophe, Staat Patrick, Bontemps L, Spor-touch C, Rioufol G, et al. Long-term benefit of postconditioning. Circulation. 2008; 117(8): 1037-1044.
29. Granfeldt Asger, Lefer David J, Vinten-Johansen J. Protective is-chaemia in patients: preconditioning and postconditioning. Cardi-ovascular Research. 2009; 83(2): 234-246.
30. Yadav SS, Sindram D, Perry DK, Clavien PA. Ischemic preconditioning protects the mouse liver by inhibition of apoptosis through a caspa-se-dependent pathway. Hepatology. 1999; 30(5): 1223-1231.
31. Ferrera R, Benhabbouche S, Bopassa JC, Li B, Ovize M. One hour reperfusion is enough to assess function and infarct size with TTC staining in Langendorff rat model. Cardiovasc Drugs Ther. 2009; 23(4):327-331.
32. Guler A, Sahin MA, Yucel O, Yokusoglu M, Gamsizkan M, Ozal E, et al. Proanthocyanidin prevents myocardial ischemic injury in adult rats. Med Sci Monit. 2011; 17(11): BR326-331.
33. Wang CZ, Mehendale SR, Calway T, Yuan CS. Botanical flavonoids on coronary heart disease. Am J Chin Med. 2011; 39(4): 661-671.
34. Song QH, Carl Atkinson, Fei Qiao, Cianflone K, Chen X, Tomlinson S. A complement-dependent balance between hepatic ische-mia/reperfusion injury and liver regeneration in mice. J Clin Invest. 2009; 119(8): 2304-2316.
35. Abas F, Alkan T, Goren B, Taskapilioglu O, Sarandol E, Tolunay S. Neuroprotective effects of postconditioning on lipid peroxidation and apoptosis after focal cerebral ischemia/reperfusion injury in rats. Turk Neurosurg. 2010; 20(1):1-8.
36. Li S, Wu J, Watanabe M, Li C, Okada T. Protective effects of ischemic postconditioning against hypoxia-reoxygenation injury and hy-drogen peroxide-induced damage in isolated rat hearts. Exp Clin Cardiol. 2006; 11(4): 280-285.
37. Sahar HK, Cottart CH, Wendum D, Vibert F, Clot JP, Savouret JF, et al. Postischemic treatment by trans-resveratrol in rat liver ische-mia-reperfusion: A possible strategy in liver surgery. Liver Transpl. 2008; 14(4):451-459.